Rejigging The Benefit-Risk Balance For Advanced Therapies In The EU

 
• By Neena Brizmohun
  
T-cells attacking cancer_1200x675
The European Medicines Agency's advanced therapy committee has released its 2017 work plan
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet